The Institute For Cancer Research
Balance Sheet
Fiscal Year Start:
Jul 1
Assets in 2024 (Year End)
$182,653,136
Other Assets
60%
Property, Plant, & Equipment (net)
17%
Receivables (Non-Related)
17%
Investments
4%
Cash & Equivalents
1%
Prepaid Expenses
<1%
Inventories
<1%
Related-Party Receivables
0%
Liabilities in 2024 (Year End)
$67,057,792
Payables & Accruals
57%
Other Liabilities
33%
Grants Payable
10%
Notes Payable / Debt (Non-Related)
<1%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$3,570,528
$2,460,601
-31%
Receivables (Non-Related)
$21,774,137
$30,464,764
+40%
Related-Party Receivables
-
-
-
Inventories
$89,194
$31,823
-64%
Prepaid Expenses
$819,619
$1,523,967
+86%
Investments
$7,384,397
$7,695,305
+4%
Property, Plant, & Equipment (net)
$29,275,906
$31,589,833
+8%
Other Assets
$101,430,632
$108,886,843
+7%
Total Assets
$164,344,413
$182,653,136
+11%
Liabilities
2023
2024
Change
Payables & Accruals
$26,083,568
$38,117,070
+46%
Grants Payable
$7,762,085
$7,027,536
-9%
Deferred Revenue
$0
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
$211,982
$71,673
-66%
Related-Party Payables
-
-
-
Other Liabilities
$21,863,889
$21,841,513
0%
Total Liabilities
$55,921,524
$67,057,792
+20%
Net assets
2023
2024
Change
Restricted Net Assets
$98,774,348
$105,441,222
+7%
Unrestricted Net Assets
$9,648,541
$10,154,122
+5%
Net assets
2023
2024
Change
Net assets
+$108,422,889
+$115,595,344
+7%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)